Royal Marsden NHS Foundation Trust
342
61
75
110
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
4.7%
16 terminated/withdrawn out of 342 trials
87.3%
+0.8% vs industry average
4%
12 trials in Phase 3/4
17%
19 of 110 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (342)
An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum
Role: collaborator
A Study of Pembrolizumab And Platinum With Radiotherapy in Cervix Cancer
Role: lead
Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.
Role: lead
Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR
Role: lead
Dose Escalation Study With Expansion to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of CCT3833
Role: lead
Combination Study of Guadecitabine/ASTX727 and Pembrolizumab
Role: lead
Pembrolizumab and Palliative Radiotherapy in Lung
Role: lead
Trial of Pembrolizumab and Radiotherapy in Melanoma
Role: lead
Assessing Health-related Quality of Life in Sarcoma Patients
Role: collaborator
Breast Cancer Evolution During Neoadjuvant Systemic Therapy
Role: lead
Identifying the Best Follow up Approach for People Who Have Had Treatment to Cure Newly Diagnosed Prostate Cancer
Role: collaborator
Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
Role: collaborator
Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression
Role: lead
The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS Study
Role: collaborator
PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
Role: lead
SURVEY-CNS: A Feasibility Study of Randomising Women and Men With HER2-Positive Metastatic Breast Cancer to Central Nervous System Surveillance Versus No Surveillance
Role: collaborator
Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions
Role: lead
B4P Trial - BLOOM43 for Preconditioning
Role: collaborator
Feasibility of Serial Multisite Image-guided Biopsy to Study Breast Cancer Evolution
Role: lead
GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmia
Role: collaborator